Evidence map›Paper›PMID 28954626›Full record

ArticleGenome medicine2017

HLAProfiler utilizes k-mer profiles to improve HLA calling accuracy for rare and common alleles in RNA-seq data.

Martin L Buchkovich, Chad C Brown, Kimberly Robasky, Shengjie Chai, Sharon Westfall, Benjamin G Vincent, Eric T Weimer, Jason G Powers

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Genome medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Neoantigens: promising targets for cancer therapy.Signal transduction and targeted therapy · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Martin L BuchkovichTranslational Genomics Department, Q2 Solutions | EA Genomics, a Quintiles Quest Joint Venture, Morrisville, NC, 27560, USA. martin.buchkovich@q2labsolutions.com.ORCID 0000-0002-4684-081X
Chad C BrownTranslational Genomics Department, Q2 Solutions | EA Genomics, a Quintiles Quest Joint Venture, Morrisville, NC, 27560, USA.
Kimberly RobaskyTranslational Genomics Department, Q2 Solutions | EA Genomics, a Quintiles Quest Joint Venture, Morrisville, NC, 27560, USA.
Shengjie ChaiLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Sharon WestfallTranslational Genomics Department, Q2 Solutions | EA Genomics, a Quintiles Quest Joint Venture, Morrisville, NC, 27560, USA.
Benjamin G VincentLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Eric T WeimerDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Jason G PowersTranslational Genomics Department, Q2 Solutions | EA Genomics, a Quintiles Quest Joint Venture, Morrisville, NC, 27560, USA.
Q2 Solutions (United States) · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human leukocyte antigen (HLA) system is a genomic region involved in regulating the human immune system by encoding cell membrane major histocompatibility complex (MHC) proteins that are responsible for self-recognition. Understanding the variation in this region provides important insights into autoimmune disorders, disease susceptibility, oncological immunotherapy, regenerative medicine, transplant rejection, and toxicogenomics. Traditional approaches to HLA typing are low throughput, target only a few genes, are labor intensive and costly, or require specialized protocols. RNA sequencing promises a relatively inexpensive, high-throughput solution for HLA calling across all genes, with the bonus of complete transcriptome information and widespread availability of historical data. Existing tools have been limited in their ability to accurately and comprehensively call HLA genes from RNA-seq data.

resultsWe created HLAProfiler ( https://github.com/ExpressionAnalysis/HLAProfiler ), a k-mer profile-based method for HLA calling in RNA-seq data which can identify rare and common HLA alleles with > 99% accuracy at two-field precision in both biological and simulated data. For 68% of novel alleles not present in the reference database, HLAProfiler can correctly identify the two-field precision or exact coding sequence, a significant advance over existing algorithms.

conclusionsHLAProfiler allows for accurate HLA calls in RNA-seq data, reliably expanding the utility of these data in HLA-related research and enabling advances across a broad range of disciplines. Additionally, by using the observed data to identify potential novel alleles and update partial alleles, HLAProfiler will facilitate further improvements to the existing database of reference HLA alleles. HLAProfiler is available at https://expressionanalysis.github.io/HLAProfiler/ .

Indexed as

Sequence Analysis, RNASoftwareAllelesCell LineHistocompatibility TestingHLA AntigensHumansMolecular Sequence DataReference ValuesHLA AntigensHLAHSCTImmunologyRNA-sequencingTransplantation

Identifiers

PMID28954626
PMCPMC5618726
OpenAlexW2760268780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.